NSC |
Compound |
Enrichment |
Correlation |
NSC 46691 |
Null |
0.0462077035966084 |
-0.21941347 |
NSC 603086 |
2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- |
0.0462077035966084 |
0.63057179 |
NSC 603555 |
2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-phenoxy phenyl)-, hydrochloride |
0.0462077035966084 |
0.57393091 |
NSC 607993 |
Null |
0.0462077035966084 |
-0.30318645 |
NSC 617823 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.0462077035966084 |
0.51513153 |
NSC 619102 |
4-Methoxy-1,5-benzothiazepine-1,1-dioxide |
0.0462077035966084 |
0.55471942 |
NSC 634785 |
4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride |
0.0462077035966084 |
0.58839922 |
NSC 639981 |
Null |
0.0462077035966084 |
0.62664904 |
NSC 642049 |
Acetamide, N-(3-acetylphenyl)-2-[(4-amino-5-mercapto- 4H-1,2,4-triazol-3-yl)hydrazino]-2-oxo- |
0.0462077035966084 |
0.12761158 |
NSC 645317 |
Sanguilutine pseudobase |
0.0462077035966084 |
0.48982234 |